Industry

CareDx Top-Tier Sponsor for Heart Failure Society of America Annual Scientific Meeting BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will host a symposium to describe the latest innovations in post-cardiac … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Devices Market Research Report by Devices (Diagnosis Devices, Surgical Devices, and Vision Care), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmology Devices Market size was estimated at USD 59.85 billion … [Read more…]

Will brings a strong track record of creating value through company-building, deep relationships with capital markets and rare disease drug development and commercialization experience Other appointments include VP of Business Development and VP of U.S. Operations to oversee global clinical and regulatory operations Company advancing several synthetic rescue-based programs for intractable genetic diseases, both in-house … [Read more…]

Retail Comparable Store Prescriptions Increased 3.1 Percent – Comparable Store Acute Prescriptions, Excluding COVID Immunizations, Increased 5.3 Percent Revenues of $5.9 billion, Compared to Prior Year Revenues of $6.1 billion Net Loss per Share of $6.07, Compared to the Prior Year Net Loss per Share of $1.86 Driven by Non-Cash Goodwill Impairment Charge Adjusted Net … [Read more…]

EDP-323 Demonstrates Potent Inhibition of RSV Replication and Associated Pathology 3D Airway Model Provides Accurate Insight into the Dynamics of RSV Infection Advances in hMPV Virology Methods Improve In Vitro Characterization of Direct-Acting Antivirals WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and … [Read more…]

Mobility and recovery app pliability announces its newest athlete signing, professional golfer Lee Westwood NEW YORK–(BUSINESS WIRE)–Today, mobility and recovery app pliability, who recently rebranded from ROMWOD, announces professional golfer Lee Westwood as the newest addition to its athlete roster. This partnership marks the next stage of pliability’s evolution to educate and demonstrate that movement … [Read more…]

Through the agreement Spectrum’s robust portfolio is leveraged to deliver more than 90 percent of upstream and downstream bioprocessing required raw materials. GARDENA, Calif.–(BUSINESS WIRE)–#BiotechWeekBoston—Spectrum Chemical Mfg. Corp., a leading global provider of specialty, fine and cGMP chemicals, as well as laboratory equipment and supplies, has entered into a new U.S. distribution agreement with DFE … [Read more…]

NEW YORK–(BUSINESS WIRE)–The majority of US states have the resources needed to get through an economic recession, according to a new study from Moody’s Analytics. A record 43 states have the cash they need to weather an economic slump without having to resort to severe spending cuts or tax increases. “States have never been in … [Read more…]

This phase 2 trial evaluates the safety, tolerability, and immunogenicity of Covigenix VAX-001-1b in healthy adults 18 years and older A total of 268 participants have been enrolled in the study at two sites in Burkina Faso, completing the single and two-dose cohorts EDMONTON, Alberta & OUAGADOUGOU, Burkina Faso–(BUSINESS WIRE)–Entos Pharmaceuticals (Entos), a clinical-stage biotechnology … [Read more…]

Subjects enrolled with biopsy confirmed NASH experienced clinically and statistically significant improvements in liver stiffness as measured by FibroScan, a non-invasive measure of liver fibrosis Subjects with NASH experienced clinically and statistically significant improvements in alanine aminotransferase (ALT), a measure of liver cell inflammation, at both dose levels of AXA1125 Findings demonstrate improvement in hepatic … [Read more…]